Lmr Partners LLP Moderna, Inc. Call Options Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $27.5 Million - $45.3 Million	272,100 Added 680.25%	312,100 $37.1 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $2.56 Million - $3.46 Million	30,000 Added 300.0%	40,000 $4.26 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $1.74 Million - $2.61 Million	-25,000 Reduced 71.43%	10,000 $994,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $3.37 Million - $4.43 Million	35,000 New	35,000 $3.62 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $157 Million - $228 Million	1,157,300 New	1,157,300 $178 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.